title: [Kidney transplantation in children].
abstract: Indications, procedures, complications, pharmacokinetics and outcomes of renal transplantation are different in children and in adults. Subjects <18 yrs old, are often included in a unique list as in Italy, benefiting from donors <15 yrs old, and the waiting time is reduced to <12 months in 71% of cases. The risk of thrombosis limits the use of donors <2 yrs and trans-plantation in infants <1 yr. The age at kidney transplantation is <5 yrs in 20-30% of children. In Italy living-related trans-plantation (LRT) is performed in 7% of cases, while in the USA it is more common (57%) and is often pre-emptive before entering dialysis (24%). Current therapy tends to reduce steroid treatment doses and, optimizing induction therapy with IL-2R inhibitors, using tacrolimus or mycophenolate or sirolimus. Transplanted patient survival is better in children than in adults (94-98% at 5 yrs). Infections, cardiovascular diseases and neoplasia induce 34, 15 and 12% of deaths, respectively, at 10 yrs; morbidity for infections and lymphoproliferative disease is increasing. Acute rejections declined from 70% in 1987 to 31% in 2002 in cadaveric transplantation (CT) and renal survival at 3 yrs increased from 50% in 1985 to 82% for CT and up to 92% in LRT. In adolescents (11-17 yrs old) renal survival is lower than in infants and in adults <65 yrs old. Renal losses are due to chronic transplant nephropathy (32%), vascular thrombosis (13%) and the recurrence of the original nephropathy (focal glomerulosclerosis up to 50%, membrano-proliferative glomerulonephritis up to 30%, and primary hyperoxaluria up to 90% if combined kidney-liver transplantation is not performed). Growth improves after transplantation particularly in children <5 yrs, while it is not completely satisfactory in adolescents. Overall, results indicate that kidney transplantation in children has very much improved and will offer in the near future even more favorable outcomes.
authors.affiliation: Struttura Complessa di Nefrologia, Dialisi e Trapianto, Ospedale Regina Margherita, Turin. nefrologia@oirmsantanna.piemonte.it
authors.forename: R
authors.initials: R
authors.lastname: Coppo
authors.forename: A
authors.initials: A
authors.lastname: Amore
authors.forename: L
authors.initials: L
authors.lastname: Peruzzi
authors.forename: G
authors.initials: G
authors.lastname: Conti
authors.forename: L
authors.initials: L
authors.lastname: Roasio
authors.forename: A
authors.initials: A
authors.lastname: Amoroso
mesh_terms: D002648:Child; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis / Q000601:surgery; D005923:Glomerulosclerosis, Focal Segmental / Q000175:diagnosis / Q000601:surgery; D006085:Graft Survival; D006801:Humans; D006959:Hyperoxaluria / Q000175:diagnosis / Q000601:surgery; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007558:Italy; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods; D011183:Postoperative Complications / Q000209:etiology; D012008:Recurrence; D009927:Tissue and Organ Procurement; D014850:Waiting Lists
chemical_list: D007166:Immunosuppressive Agents